Publication:
Imaging Spectrum of Intrahepatic Mass-Forming Cholangiocarcinoma and Its Mimickers: How to Differentiate Them Using MRI

dc.contributor.authorKovač, Jelena Djokic (52563972900)
dc.contributor.authorJanković, Aleksandra (57205752179)
dc.contributor.authorÐikić-Rom, Aleksandra (56182303300)
dc.contributor.authorGrubor, Nikica (6701410404)
dc.contributor.authorAntić, Andrija (6603457520)
dc.contributor.authorDugalić, Vladimir (9433624700)
dc.date.accessioned2025-06-12T12:58:04Z
dc.date.available2025-06-12T12:58:04Z
dc.date.issued2022
dc.description.abstractIntrahepatic cholangiocarcinoma (ICC) is the second most common primary hepatic malignancy, with mass-forming growth pattern being the most common. The typical imaging appearance of mass-forming ICC (mICC) consists of irregular ring enhancement in the arterial phase followed by the progressive central enhancement on portal venous and delayed phases. However, atypical imaging presentation in the form of hypervascular mICC might also be seen, which can be attributed to distinct pathological characteristics. Ancillary imaging features such as lobular shape, capsular retraction, segmental biliary dilatation, and vascular encasement favor the diagnosis of mICC. Nevertheless, these radiological findings may also be present in certain benign conditions such as focal confluent fibrosis, sclerosing hemangioma, organizing hepatic abscess, or the pseudosolid form of hydatid disease. In addition, a few malignant lesions including primary liver lymphoma, hemangioendothelioma, solitary hypovascular liver metastases, and atypical forms of hepatocellular carcinoma (HCC), such as scirrhous HCC, infiltrative HCC, and poorly differentiated HCC, may also pose a diagnostic dilemma by simulating mICC in imaging studies. Diffusion-weighted imaging and the use of hepatobiliary contrast agents might be helpful for differential diagnosis in certain cases. The aim of this manuscript is to provide a comprehensive overview of mICC imaging features and to describe useful tips for differential diagnosis with its potential mimickers. © 2022 by the authors. Licensee MDPI, Basel, Switzerland.
dc.identifier.urihttps://doi.org/10.3390/curroncol29020061
dc.identifier.urihttps://www.scopus.com/inward/record.uri?eid=2-s2.0-85123923636&doi=10.3390%2fcurroncol29020061&partnerID=40&md5=423b1888eccd87ff22e010797d0bbcb5
dc.identifier.urihttps://remedy.med.bg.ac.rs/handle/123456789/3667
dc.subjectMagnetic resonance imaging
dc.subjectMass-forming cholangiocarcinoma
dc.subjectMimickers
dc.titleImaging Spectrum of Intrahepatic Mass-Forming Cholangiocarcinoma and Its Mimickers: How to Differentiate Them Using MRI
dspace.entity.typePublication

Files